271 related articles for article (PubMed ID: 9726394)
1. Trends in prescribing H2-receptor antagonists and proton pump inhibitors in primary care.
Martin RM; Lim AG; Kerry SM; Hilton SR
Aliment Pharmacol Ther; 1998 Aug; 12(8):797-805. PubMed ID: 9726394
[TBL] [Abstract][Full Text] [Related]
2. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
Mattos ÂZ; Marchese GM; Fonseca BB; Kupski C; Machado MB
Arq Gastroenterol; 2017 Dec; 54(4):271-280. PubMed ID: 28954042
[TBL] [Abstract][Full Text] [Related]
3. The changing role of H2-receptor antagonists in acid-related diseases.
Lamers CB
Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S3-7. PubMed ID: 8930573
[TBL] [Abstract][Full Text] [Related]
4. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
Bardhan KD
Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
[TBL] [Abstract][Full Text] [Related]
5. Impact of the reclassification of omeprazole on the prescribing and sales of ulcer healing drugs.
Dhippayom T; Walker R
Pharm World Sci; 2006 Aug; 28(4):194-8. PubMed ID: 17066243
[TBL] [Abstract][Full Text] [Related]
6. Prescribing trends of proton pump inhibitors and histamine blockers among children in the United Kingdom (1998-2019): A population-based assessment.
Masarwa R; Reynier P; Lefebvre C; Platt RW; Delaney JAC; Filion KB
Pharmacoepidemiol Drug Saf; 2024 Feb; 33(2):e5752. PubMed ID: 38362652
[TBL] [Abstract][Full Text] [Related]
7. A practice-based approach for converting from proton pump inhibitors to less costly therapy.
Lucas LM; Gerrity MS; Anderson T
Eff Clin Pract; 2001; 4(6):263-70. PubMed ID: 11769299
[TBL] [Abstract][Full Text] [Related]
8. Dyspepsia and reflux in primary care: rough DIAMOND of a trial.
van Zanten SV
Lancet; 2009 Jan; 373(9659):187-8. PubMed ID: 19150689
[No Abstract] [Full Text] [Related]
9. Meta-analysis: proton pump inhibitors vs. H2-receptor antagonists--their efficacy with antibiotics in Helicobacter pylori eradication.
Gisbert JP; Khorrami S; Calvet X; Gabriel R; Carballo F; Pajares JM
Aliment Pharmacol Ther; 2003 Oct; 18(8):757-66. PubMed ID: 14535868
[TBL] [Abstract][Full Text] [Related]
10. Histamine receptor antagonists, proton pump inhibitors and their combination in the treatment of gastro-oesophageal reflux disease.
Katz PO; Tutuian R
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):371-84. PubMed ID: 11403533
[TBL] [Abstract][Full Text] [Related]
11. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
Holtmann G; Layer P; Goebell H
Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
[TBL] [Abstract][Full Text] [Related]
12. Proton-pump inhibitors are the treatment of choice in acid-related disease.
Brunner G
Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S9-13. PubMed ID: 8930574
[TBL] [Abstract][Full Text] [Related]
13. Gastric acid suppressants--too much of a good thing?
Logan IC; Sumukadas D; Witham MD
Age Ageing; 2010 Jul; 39(4):410-1. PubMed ID: 20507846
[No Abstract] [Full Text] [Related]
14. Cost analysis of a provincial drug program to guide the treatment of upper gastrointestinal disorders.
Bursey F; Crowley M; Janes C; Turner CJ
CMAJ; 2000 Mar; 162(6):817-23. PubMed ID: 10750472
[TBL] [Abstract][Full Text] [Related]
15. Risk of post-stroke pneumonia with proton pump inhibitors, H2 receptor antagonists and mucoprotective agents: A retrospective nationwide cohort study.
Song TJ; Kim J
PLoS One; 2019; 14(5):e0216750. PubMed ID: 31067267
[TBL] [Abstract][Full Text] [Related]
16. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of H2-receptor antagonists.
Andrade SE; Gurwitz JH; Fish LS
Med Care; 1999 Apr; 37(4):424-30. PubMed ID: 10213023
[TBL] [Abstract][Full Text] [Related]
17. Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database.
Bashford JN; Norwood J; Chapman SR
BMJ; 1998 Aug; 317(7156):452-6. PubMed ID: 9703528
[TBL] [Abstract][Full Text] [Related]
18. Review article: acid suppression in the management of gastro-oesophageal reflux disease--an appraisal of treatment options in primary care.
Jones R; Bytzer P
Aliment Pharmacol Ther; 2001 Jun; 15(6):765-72. PubMed ID: 11380314
[TBL] [Abstract][Full Text] [Related]
19. [Update on current care guidelines. A current care guideline: recurrent upper gastrointestinal symptoms].
Paikka N
Duodecim; 2012; 128(22):2376-7. PubMed ID: 23342484
[TBL] [Abstract][Full Text] [Related]
20. Eradication of Helicobacter pylori does not decrease the long-term use of acid-suppressive medication.
Tan AC; Hartog GD; Mulder CJ
Aliment Pharmacol Ther; 1999 Nov; 13(11):1519-22. PubMed ID: 10571610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]